Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Bonds

FS KKR Capital: Dividend Stability Under Scrutiny

Dieter Jaworski by Dieter Jaworski
November 10, 2025
in Bonds, Dividends, Earnings
0
FS KKR Capital Stock
0
SHARES
21
VIEWS
Share on FacebookShare on Twitter

FS KKR Capital’s latest quarterly report presents investors with conflicting signals about the business development company’s financial health. While the firm demonstrated modest growth in net asset value, it fell short of revenue projections, and its adjusted distribution yield continued its downward trend, raising questions about the sustainability of its generous dividend payments.

Quarterly Performance Analysis

For the third quarter of 2025, FS KKR reported adjusted net investment income of $0.57 per share. Although this figure matched analyst projections, it represents a notable decline from the $0.62 per share recorded in the previous quarter. More concerning was the company’s revenue performance, which reached $373 million—missing expectations by 0.82% and falling substantially below the $441 million generated during the same period last year.

A solitary positive emerged from the results: the net asset value per share experienced slight improvement, climbing to $21.99 from $21.93 at the end of June.

Portfolio Composition and Performance

The investment portfolio maintained by FS KKR totals $13.4 billion, with secured senior loans comprising 63.2% of holdings. The average annual yield on income-producing investments showed a minor contraction, decreasing from 10.8% to 10.6%. However, the company did achieve modest progress in managing non-accrual loans:

Should investors sell immediately? Or is it worth buying FS KKR Capital?

  • Portfolio at fair value: 2.9% (down from 3.0% previous quarter)
  • Portfolio at amortized cost: 5.0% (down from 5.3% previous quarter)

Current Dividend Position

Despite the weaker operational results, FS KKR has maintained its distribution policy without alteration. The quarterly dividend of $0.70 per share, declared on October 8, 2025, consists of two components:

  • Base dividend: $0.64
  • Supplemental dividend: $0.06

Shareholders of record as of December 3, 2025, will receive this payment on December 17, 2025. The critical question facing investors is whether the company can continue supporting this elevated payout level if earnings continue to deteriorate.

Forward Outlook

Market attention now turns to the upcoming quarter, where analysts project earnings of $0.56 per share alongside revenue of $377.6 million. The central uncertainty remains whether FS KKR can preserve both its portfolio quality and distribution strategy within the current economic climate, or whether the attractive dividend yield may face potential adjustment in the near future.

Ad

FS KKR Capital Stock: Buy or Sell?! New FS KKR Capital Analysis from March 25 delivers the answer:

The latest FS KKR Capital figures speak for themselves: Urgent action needed for FS KKR Capital investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

FS KKR Capital: Buy or sell? Read more here...

Tags: FS KKR Capital
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Talphera Stock
Analysis

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Next Post
Lennar Stock

Government Shutdown Halts Lennar's Acquisition Timeline

Affirm Holdings Stock

Affirm Holdings Soars on Stellar Quarterly Performance

Super Micro Computer Stock

Super Micro Stock: A Clash Between Present Challenges and Future Promise

Recommended

Banner Stock

All Eyes on Fed as Banner Corporation Awaits Rate Decision

6 months ago
Dynatrace Holdings LLC Stock

Dynatrace Holdings LLC Stock: Strong Q1 Performance Beats Expectations

8 months ago
MP Materials Stock

MP Materials: Record Production Amid Financial Headwinds

4 months ago
Omv Stock

OMV Faces Critical Juncture as Qatar Threatens European Gas Supplies

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Trending

Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

by Jackson Burston
March 25, 2026
0

Fair Isaac Corporation, the company behind the ubiquitous FICO credit score, is facing a dual-pronged assault that...

Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance
  • Figma Embraces Third-Party AI to Power Its Design Ecosystem
  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com